Kestra Medical Technologies Return on Tangible Equity 2025-2025 | KMTS

Current and historical return on tangible equity values for Kestra Medical Technologies (KMTS) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Kestra Medical Technologies Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2025-07-31 $-0.10B $0.18B -103.86%
2025-04-30 $-0.10B $0.21B -189.27%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $1.486B $0.060B
Kestra Medical Technologies, Ltd. is a commercial-stage wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies. Kestra Medical Technologies, Ltd. is based in KIRKLAND, Wash.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $192.719B 21.52
EssilorLuxottica (ESLOY) France $140.970B 0.00
Stryker (SYK) United States $137.019B 26.29
Medtronic (MDT) Ireland $131.919B 18.28
Boston Scientific (BSX) United States $113.066B 25.01
Medline (MDLN) United States $62.139B 0.00
Lonza Group Ag (LZAGY) Switzerland $46.969B 0.00
ResMed (RMD) United States $39.571B 26.42
GE HealthCare Technologies (GEHC) United States $36.756B 17.61
Agilent Technologies (A) United States $36.736B 23.22
Koninklijke Philips (PHG) Netherlands $28.368B 18.53
Terumo (TRUMY) Japan $19.441B 21.97
Zimmer Biomet Holdings (ZBH) United States $17.819B 11.11
Insulet (PODD) United States $17.019B 52.82
Smith & Nephew SNATS (SNN) United Kingdom $14.739B 0.00
Baxter (BAX) United States $11.170B 9.02
Sunny Optical Technology (SNPTF) China $8.485B 0.00
Bio-Rad Laboratories (BIO) United States $8.133B 29.24
Demant (WILYY) Denmark $6.521B 0.00
Envista Holdings (NVST) United States $4.785B 24.25
Lantheus Holdings (LNTH) United States $4.303B 13.11
BillionToOne (BLLN) United States $4.147B 0.00
ICU Medical (ICUI) United States $3.806B 24.16
Shandong Weigao Medical Polymer (SHWGF) China $3.263B 0.00
Prestige Consumer Healthcare (PBH) United States $3.189B 14.81
Haemonetics (HAE) United States $2.778B 12.06
Neogen (NEOG) United States $2.349B 51.43
Phibro Animal Health (PAHC) United States $2.151B 18.95
Perrigo (PRGO) Ireland $2.015B 5.05
LeMaitre Vascular (LMAT) United States $1.983B 39.92
QuidelOrtho (QDEL) United States $1.977B 12.71
AtriCure (ATRC) United States $1.845B 0.00
Curaleaf Holdings (CURLF) Canada $1.622B 0.00
Green Thumb Industries (GTBIF) United States $1.475B 64.64
AdaptHealth (AHCO) United States $1.442B 20.88
Capricor Therapeutics (CAPR) United States $1.130B 0.00
BioLife Solutions (BLFS) United States $1.080B 320.43
Lumexa Imaging Holdings (LMRI) United States $1.021B 0.00
InMode (INMD) Israel $0.953B 10.77
Tilray Brands (TLRY) Canada $0.883B 0.00
Valneva SE (VALN) France $0.817B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.803B 0.00
Omeros (OMER) United States $0.796B 0.00
CeriBell (CBLL) United States $0.747B 0.00
VAREX IMAGING (VREX) United States $0.587B 15.91
Verano Holdings (VRNO) United States $0.454B 0.00
Brainsway (BWAY) Israel $0.427B 72.60
Cerus (CERS) United States $0.423B 0.00
Canopy Growth (CGC) Canada $0.405B 0.00
Cresco Labs (CRLBF) United States $0.377B 0.00
Viemed Healthcare (VMD) United States $0.328B 26.18
SEMPERIT AG HLD (SEIGY) Austria $0.309B 0.00
Evolus (EOLS) United States $0.292B 0.00
Quanterix (QTRX) United States $0.284B 0.00
TriSalus Life Sciences (TLSI) United States $0.237B 0.00
Sanuwave Health (SNWV) United States $0.222B 0.00
Owens & Minor (OMI) United States $0.217B 2.17
TerrAscend (TSNDF) Canada $0.208B 0.00
Organigram Global (OGI) Canada $0.207B 0.00
High Tide (HITI) Canada $0.207B 0.00
Utah Medical Products (UTMD) United States $0.197B 17.71
Aurora Cannabis (ACB) Canada $0.197B 58.00
OraSure Technologies (OSUR) United States $0.194B 0.00
Accendra Health (ACH) United States $0.185B 1.85
Sanara MedTech (SMTI) United States $0.180B 0.00
Vireo Growth (VREOF) United States $0.179B 0.00
Quipt Home Medical (QIPT) United States $0.157B 0.00
Apyx Medical (APYX) United States $0.148B 0.00
FitLife Brands (FTLF) United States $0.144B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.136B 0.00
Fonar (FONR) United States $0.115B 16.72
MacroGenics (MGNX) United States $0.115B 0.00
Biote (BTMD) United States $0.102B 4.46
Jushi Holdings (JUSHF) United States $0.100B 0.00
Exagen (XGN) United States $0.080B 0.00
ImmuCell (ICCC) United States $0.056B 24.00
Sharps Technology (STSS) United States $0.048B 0.00
Cytosorbents (CTSO) United States $0.042B 0.00
Rockwell Medical (RMTI) United States $0.042B 0.00
Nephros (NEPH) United States $0.041B 29.77
Veru (VERU) United States $0.038B 0.00
Modular Medical (MODD) United States $0.034B 0.00
United-Guardian (UG) United States $0.033B 16.63
Jin Medical (ZJYL) China $0.022B 0.00
Bonk (BNKK) United States $0.021B 0.00
Allurion Technologies (ALUR) United States $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.013B 0.00
ZeroStack (ZSTK) United States $0.010B 0.00
Flora Growth (FLGC) United States $0.009B 0.00
INLIF (INLF) China $0.009B 0.00
Innovative Eyewear (LUCY) United States $0.006B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
Zynex (ZYXI) United States $0.004B 0.00
Functional Brands (MEHA) United States $0.003B 0.00
Agape ATP (ATPC) $0.002B 0.00
Meihua Medical Technologies (MHUA) China $0.002B 0.00
Akanda (AKAN) Canada $0.002B 0.00
GlucoTrack (GCTK) United States $0.002B 0.00
InterCure (INCR) Israel $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00
SNDL (SNDL) Canada $0.000B 0.00
Trinity Biotech (TRIB) Ireland $0.000B 0.00